TOWER cold chain have the huge pleasure of announcing the addition of TWO Non-Executive Directors to the board.

By December 3, 2020Uncategorized

Dr Debra Ainge brings over 20 years’ experience in the pharmaceutical industry in both large and small to mid-size companies and held global positions in Research & Development, Speciality Pharmaceuticals and Pharmaceutical Services Organisations. Debra is a non-executive director of Pleco Therapeuticls, and recently worked as Chief Operating Officer in Parexel Informatics and Clinigen PLC.

Prior to this, she oversaw several major acquisitions including Idis, Link and Quantum Pharma.

Debra commenced her career at AstraZeneca where she performed various R&D roles and was involved in the development of multiple NCEs in Respiratory, Oncology, CNS and GI. She is a certified member of the Institute of Directors and holds a degree and PhD from Newcastle University, and completed post-doctoral studies at the University of Lausanne (Switzerland).

Mark Parsons FCILT has spent over 30 years working in across the Supply Chain industry, and the last decade placing the customer at the centre of his business activities and ethos. Mark spent 14 years with DHL, where he was Chief Customer Officer and Director of DHL Supply Chain UK Limited. As part of leading the strategic growth agenda he developed the Customer4Life initiative which became the global Customer Experience program.

Mark led over 100 Sales, Account, Marketing and Product Development managers and took a particular interest in sales enablement, implementing Salesforce and championing the development of the global Sales BI (Business Intelligence) data suite.

Prior to 2004, he worked for 4 years at Accenture in the UK & Australia as a Management Consultant focused on re-engineering manufacturing supply chains, for 5 years working in the US for Invensys as global Procurement lead for Logistics and Packaging and a further 4 years working in various general management and supply chain change roles for Electrolux across Europe.

We look forward to working with, gaining insight and learning from them both in 2021 and beyond.